Larvol Veri

FIP1L1-PDGFRA fusion FIP1L1-PDGFRA fusion	Chronic Eosinophilic Leukemia Chronic Eosinophilic Leukemia	imatinib Sensitive: A1 - Approval imatinib Sensitive : A1
KIT M541L KIT M541L	Chronic Eosinophilic Leukemia Chronic Eosinophilic Leukemia	imatinib Sensitive: C3 – Early Trials imatinib Sensitive : C3
PCM1-JAK2 fusion PCM1-JAK2 fusion	Chronic Eosinophilic Leukemia Chronic Eosinophilic Leukemia	ruxolitinib Sensitive: C3 – Early Trials ruxolitinib Sensitive : C3
FIP1L1-PDGFRA fusion FIP1L1-PDGFRA fusion	Chronic Eosinophilic Leukemia Chronic Eosinophilic Leukemia	YD312 Sensitive: C4 – Case Studies YD312 Sensitive : C4

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and